John Scribner > Weil, Gotshal & Manges LLP > Washington DC, United States > Lawyer Profile
Weil, Gotshal & Manges LLP Offices
2001 M STREET, NW, SUITE 600
WASHINGTON, DC 20036
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
John Scribner
Work Department
Antitrust/Competition
Position
Partner
Career
John Scribner represents clients on their most significant antitrust merger matters. He has played a lead role in obtaining FTC and DOJ regulatory approval for antitrust-sensitive transactions in numerous industries and possesses significant experience in the high-tech and pharmaceutical space. He has successfully managed the antitrust review process for complex, global transactions that were subject to in-depth investigations in the US, EC, China, Korea, Japan, Brazil and Mexico. Prior to Weil, Mr. Scribner was with the FTC and was involved in merger and non-merger investigations in a wide range of industries, including defense, pharmaceuticals, aviation, energy, industrial products, medical devices and high-tech. While at the FTC, he received the Award for Superior Service and the Award for Meritorious Service.
Top Tier Firm Rankings
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Antitrust > Merger control
- Intellectual property > Patents: licensing
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Media, technology and telecoms > Technology transactions
- Tax > US taxes: non-contentious
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: equity offerings
- Intellectual property > Copyright
- Tax > Financial products
- Tax > International tax
- Labor and employment > Labor and employment disputes (including collective actions)
- Media, technology and telecoms > Media and entertainment: litigation
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Finance > Structured finance: securitization
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Labor and employment > Workplace and employment counseling
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Civil litigation/class actions: defense
- Energy > Energy transactions: oil and gas
- Healthcare > Life sciences
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate
- Industry focus > Sport
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Intellectual property > Trademarks: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense